TrovaGene - Stock Price History | TROV

Historical daily share price chart and data for TrovaGene since 2019 adjusted for splits. The latest closing stock price for TrovaGene as of November 15, 2019 is 1.52.
  • The all-time high TrovaGene stock closing price was 1926.72 on June 08, 2005.
  • The TrovaGene 52-week high stock price is 9.65, which is 534.9% above the current share price.
  • The TrovaGene 52-week low stock price is 0.88, which is 42.1% below the current share price.
  • The average TrovaGene stock price for the last 52 weeks is 2.82.
TrovaGene Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 12.5890 21.9644 33.3427 3.0834 3.1524 -85.76%
2017 76.4910 147.6295 172.8346 18.0036 22.1444 -85.36%
2016 320.8556 373.0346 495.4591 144.0288 151.2303 -61.11%
2015 513.0598 352.8706 957.0715 310.3821 388.8778 25.58%
2014 343.1264 420.5641 485.3771 216.0360 309.6620 -25.09%
2013 488.8006 499.0599 721.5844 351.4303 413.3627 -17.17%
2012 291.7089 237.6000 533.6268 155.5511 499.0599 110.04%
2011 192.8400 207.3600 410.4000 56.1600 237.6000 5.77%
2010 211.9371 328.3200 328.3200 90.7200 224.6400 -30.67%
2009 195.2571 142.5600 341.2800 133.9200 324.0000 127.27%
2008 185.7258 289.4400 289.4400 129.6000 142.5600 -50.75%
2007 320.0070 432.0001 453.6001 216.0000 289.4400 -38.53%
2006 608.9135 803.5201 898.5601 172.8000 470.8801 -40.76%
2005 1187.8116 1728.0002 1926.7202 777.6001 794.8801 -54.00%
2004 1691.6110 1620.0002 1879.2002 1620.0002 1728.0002 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.012B $0.000B
Trovagene is a clinical-stage, oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target mitosis (cell division) to treat various types of cancer, including leukemias, lymphomas and solid tumors. Trovagene has intellectual property and proprietary technology that enables the Company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $129.829B 14.96
CSL (CSLLY) Australia $82.928B 0.00
Gilead Sciences (GILD) United States $80.729B 10.00
Celgene (CELG) United States $78.303B 11.18
Vertex Pharmaceuticals (VRTX) United States $52.716B 53.81
Biogen (BIIB) United States $49.649B 8.52
Illumina (ILMN) United States $43.871B 48.13
Regeneron Pharmaceuticals (REGN) United States $37.153B 16.27
Alexion Pharmaceuticals (ALXN) United States $23.432B 11.57
Seattle Genetics (SGEN) United States $19.416B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.631B 0.00
Incyte (INCY) United States $18.479B 42.90
BioMarin Pharmaceutical (BMRN) United States $13.576B 0.00
Genmab (GNMSF) Denmark $13.448B 59.40
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Exact Sciences (EXAS) United States $10.288B 0.00
Alnylam Pharmaceuticals (ALNY) United States $10.085B 0.00
Galapagos (GLPG) Belgium $10.076B 25.96
BeiGene (BGNE) Cayman Islands $9.325B 0.00
QIAGEN (QGEN) Netherlands $8.407B 27.41
Bio-Techne Corp (TECH) United States $7.759B 51.93
Amarin (AMRN) Ireland $7.677B 0.00
Guardant Health (GH) United States $7.264B 0.00
Sarepta Therapeutics (SRPT) United States $7.261B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.004B 0.00
Reata Pharmaceuticals (RETA) United States $6.125B 0.00
Moderna (MRNA) United States $6.112B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.583B 14.19
ARGENX SE-ADR (ARGX) Netherlands $5.236B 0.00
Exelixis (EXEL) United States $5.062B 14.24
Ascendis Pharma (ASND) Denmark $4.702B 0.00
China Biologic Products (CBPO) China $4.594B 25.88
Spark Therapeutics (ONCE) United States $4.269B 0.00
Repligen (RGEN) United States $4.252B 77.06
Bluebird Bio (BLUE) United States $4.081B 0.00
Mirati Therapeutics (MRTX) United States $4.069B 0.00
Medicines (MDCO) United States $4.057B 0.00
Blueprint Medicines (BPMC) United States $3.547B 0.00
Adaptive Biotechnologies (ADPT) United States $3.393B 0.00
Immunomedics (IMMU) United States $3.345B 0.00
MorphoSys AG (MOR) Germany $3.294B 0.00
Alkermes (ALKS) Ireland $3.139B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.040B 0.00
Genmab (GMAB) Denmark $2.840B 5.85
Emergent Biosolutions (EBS) United States $2.806B 27.87
Intercept Pharmaceuticals (ICPT) United States $2.718B 0.00
Halozyme Therapeutics (HALO) United States $2.710B 0.00
NeoGenomics (NEO) United States $2.451B 130.44
MyoKardia (MYOK) United States $2.419B 0.00
Amicus Therapeutics (FOLD) United States $2.382B 0.00
UniQure (QURE) Netherlands $2.293B 0.00
Acceleron Pharma (XLRN) United States $2.282B 0.00
Arena Pharmaceuticals (ARNA) United States $2.276B 5.29
Zai Lab (ZLAB) China $2.262B 0.00
RA PHARMCTL INC (RARX) United States $2.197B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.125B 0.00
Cambrex (CBM) United States $2.019B 25.47
Ligand Pharmaceuticals (LGND) United States $1.841B 35.41
Myriad Genetics (MYGN) United States $1.823B 26.93
Akcea Therapeutics (AKCA) United States $1.794B 0.00
Insmed (INSM) United States $1.716B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.588B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.460B 0.00
Denali Therapeutics (DNLI) United States $1.440B 0.00
Zymeworks (ZYME) Canada $1.417B 0.00
Epizyme (EPZM) United States $1.390B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.380B 0.00
REGENXBIO (RGNX) United States $1.337B 0.00
Coherus BioSciences (CHRS) United States $1.331B 0.00
Innoviva (INVA) United States $1.235B 3.64
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Editas Medicine (EDIT) United States $1.163B 0.00
Sangamo Therapeutics (SGMO) United States $1.096B 0.00
Alector (ALEC) United States $1.069B 0.00
Fate Therapeutics (FATE) United States $1.067B 0.00
Zealand Pharma (ZEAL) Denmark $1.060B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.031B 0.00
Arvinas (ARVN) United States $1.014B 0.00
Principia Biopharma (PRNB) United States $1.004B 0.00
WAVE Life Sciences (WVE) Singapore $0.956B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.888B 0.00
Codexis (CDXS) United States $0.878B 0.00
Athenex (ATNX) United States $0.870B 0.00
Cara Therapeutics (CARA) United States $0.858B 0.00
Anika Therapeutics (ANIK) United States $0.853B 27.67
Vericel (VCEL) United States $0.829B 309.00
Vanda Pharmaceuticals (VNDA) United States $0.826B 6.95
ZIOPHARM Oncology Inc (ZIOP) United States $0.795B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.711B 181.72
Twist Bioscience (TWST) United States $0.700B 0.00
Revance Therapeutics (RVNC) United States $0.685B 0.00
DBV Technologies S.A (DBVT) France $0.675B 0.00
ANI Pharmaceuticals (ANIP) United States $0.673B 11.47
Intellia Therapeutics (NTLA) United States $0.661B 0.00
MiMedx (MDXG) United States $0.650B 0.00
Mesoblast (MESO) Australia $0.600B 0.00
Precision BioSciences (DTIL) United States $0.599B 0.00
Adverum Biotechnologies (ADVM) United States $0.582B 0.00
Cellectis S.A (CLLS) France $0.581B 0.00
GENFIT S.A (GNFT) France $0.579B 0.00
BioDelivery Sciences (BDSI) United States $0.558B 0.00
Retrophin (RTRX) United States $0.555B 0.00
UROGEN PHARMA (URGN) United States $0.550B 0.00
Agenus (AGEN) United States $0.514B 0.00
Kadmon Holdings (KDMN) United States $0.508B 0.00
Dynavax Technologies (DVAX) United States $0.489B 0.00
Intra-Cellular Therapies (ITCI) United States $0.489B 0.00
Cytokineticsorporated (CYTK) United States $0.479B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Stemline Therapeutics (STML) United States $0.475B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.473B 0.00
AC Immune SA (ACIU) Switzerland $0.464B 10.73
Sinovac Biotech (SVA) China $0.460B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.448B 0.00
PHARMA MAR SA (PHMMF) Spain $0.432B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
Arcus Biosciences (RCUS) United States $0.366B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.363B 2.51
Cellular Biomedicine (CBMG) United States $0.347B 0.00
Clovis Oncology (CLVS) United States $0.346B 0.00
Bellus Health (BLU) Canada $0.339B 0.00
PDL BioPharma (PDLI) United States $0.338B 8.46
AMAG Pharmaceuticals (AMAG) United States $0.334B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.312B 0.00
Kindred Biosciences (KIN) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.295B 0.00
Avid Bioservices (CDMO) United States $0.295B 0.00
Protagonist Therapeutics (PTGX) United States $0.294B 0.00
Compugen (CGEN) Israel $0.285B 0.00
Theratechnologies (THTX) Canada $0.279B 0.00
Geron (GERN) United States $0.274B 0.00
Seres Therapeutics (MCRB) United States $0.260B 0.00
Gritstone Oncology (GRTS) United States $0.256B 0.00
Sutro Biopharma (STRO) United States $0.250B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.00
CytomX Therapeutics (CTMX) United States $0.244B 0.00
MannKind (MNKD) United States $0.244B 0.00
Scholar Rock Holding (SRRK) United States $0.243B 0.00
ADMA Biologics Inc (ADMA) United States $0.240B 0.00
Kamada (KMDA) Israel $0.240B 7.01
Albireo Pharma (ALBO) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.226B 0.00
Syros Pharmaceuticals (SYRS) United States $0.221B 0.00
Inovio Pharmaceuticals (INO) United States $0.220B 0.00
XOMA (XOMA) United States $0.218B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Athersys (ATHX) United States $0.212B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.211B 0.00
Sorrento Therapeutics (SRNE) United States $0.211B 0.00
Exicure (XCUR) United States $0.208B 0.00
OSMOTICA PHARM (OSMT) United States $0.207B 0.00
Cue Biopharma (CUE) United States $0.207B 0.00
Spero Therapeutics (SPRO) United States $0.196B 0.00
Affimed (AFMD) Germany $0.185B 0.00
ChromaDex (CDXC) United States $0.184B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.183B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.166B 0.00
Dyadic (DYAI) United States $0.163B 0.00
Senesco Technologies (ELOX) United States $0.162B 0.00
Arsanis (XFOR) United States $0.161B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.154B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Alcobra (ARCT) United States $0.146B 0.00
Emmaus Life Sciences (EMMA) United States $0.135B 0.00
Cerecor (CERC) United States $0.133B 0.00
Five Prime Therapeutics (FPRX) United States $0.133B 0.00
Enzo Biochem (ENZ) United States $0.133B 0.00
Prometic Life Sciences (PFSCF) Canada $0.132B 0.00
Northwest Biotherapeutics (NWBO) United States $0.132B 0.00
Ophthotech (ISEE) United States $0.132B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Mersana Therapeutics (MRSN) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.123B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Fortress Biotech (FBIO) United States $0.117B 0.00
Abeona Therapeutics (ABEO) United States $0.116B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.112B 0.00
Novavax (NVAX) United States $0.112B 0.00
NantKwest (NK) United States $0.110B 0.00
Aptinyx (APTX) United States $0.109B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
OvaScience (MLND) United States $0.104B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.104B 0.00
VBI Vaccines (VBIV) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aduro Biotech (ADRO) United States $0.091B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Acorda Therapeutics (ACOR) United States $0.088B 0.00
Arbutus Biopharma (ABUS) Canada $0.087B 0.00
Celyad SA (CYAD) Belgium $0.086B 0.00
Adocia (ADOCY) France $0.086B 0.00
Strongbridge Biopharma (SBBP) United States $0.085B 2.26
VTv Therapeutics (VTVT) United States $0.084B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.084B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.079B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.078B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Verastem (VSTM) United States $0.070B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.067B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Selecta Biosciences (SELB) United States $0.067B 0.00
Checkpoint Therapeutics (CKPT) United States $0.066B 0.00
Catalyst Biosciences (CBIO) United States $0.064B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.062B 0.00
NewLink Genetics (NLNK) United States $0.060B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.054B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.052B 0.00
Applied Genetic Technologies (AGTC) United States $0.052B 0.00
China Health Industries Holdings (CHHE) China $0.052B 15.78
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Organovo Holdings (ONVO) United States $0.050B 0.00
Curis (CRIS) United States $0.048B 0.00
Orgenesis (ORGS) United States $0.048B 3.13
AquaBounty Technologies (AQB) United States $0.047B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Clearside Biomedical (CLSD) United States $0.044B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
AIT Therapeutics (XAIR) United States $0.043B 0.00
DiaMedica Therapeutics (DMAC) United States $0.039B 0.00
Evogene (EVGN) Israel $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
Stellar Biotechnologies (EDSA) Canada $0.036B 0.00
Oncobiologics (OTLK) United States $0.032B 0.00
Unum Therapeutics (UMRX) United States $0.031B 0.00
Celsion (CLSN) United States $0.031B 0.00
VIVUS (VVUS) United States $0.030B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 9.93
Caladrius Biosciences (CLBS) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.028B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Apricus Biosciences (SEEL) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Aytu Bioscience (AYTU) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Novogen (KZIA) Australia $0.020B 0.00
CollPlant Holdings (CLGN) Israel $0.017B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
VistaGen Therapeutics (VTGN) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.002B 0.00